Assets Lave om Dato
AbbVie USD 136.22B 854M 2023-09
Actinium Pharmaceuticals USD 88.94M 10.11M 2023-09
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
Arrowhead Research USD 626.29M 139.27M 2023-12
Astellas Pharma JPY 3.54T 745.06B 2023-09
AstraZeneca USD 96.09B 457M 2023-09
Bayer EUR 117.24B 4.43B 2023-09
Biogen USD 26.84B 1.35B 2023-12
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Incyte USD 6.78B 393.87M 2023-12
J&J USD 166.06B 25.62B 2023-09
Merck USD 106.73B 2.26B 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Roche Holding CHF 84.37B 3.78B 2023-06
Takeda JPY 14.87T 79.15B 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
TG Therapeutics USD 329.59M 1.48M 2023-12



Spectrum Pharmaceuticals Aktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.